AptarGroup, Inc. (ATR) Institutional Ownership & Insider Trading

553 institutions reported holding AptarGroup, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 18 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ATRAptarGroup, Inc.Follow ATR — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 8.0B
P/E TTM: 22.8
Dividend yield: 1.5%
52-week: —
Next earnings: 29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

553 institutions held 96.3% of the shares. Across filers that reported both quarters, shares held changed +2.6%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	553	61	+2.6%	170	55	188	52
Mar 26	539	59	+0.1%	186	70	148	38
Dec 25	498	60	-3.5%	160	58	160	54
Sep 25	484	61	-0.6%	134	49	172	53
Jun 25	493	62	+1.1%	154	52	137	35
Mar 25	486	61	+0.8%	148	44	147	49
Dec 24	492	61	+0.0%	144	50	119	28
Sep 24	460	59	-7.9%	140	38	130	37

AptarGroup, Inc. — questions

Who owns AptarGroup, Inc. stock?: 553 institutions reported AptarGroup, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (9.7%), STATE FARM MUTUAL AUTOMOBILE INSURANCE CO (7.5%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.7%).
Are AptarGroup, Inc. insiders buying or selling?: 18 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from AptarGroup, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.